These pharma stocks are dropping like flies.
Immediate targets 0.29, 0.16. Invalidation at 0.83
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere...
Price above SMA13
OBV>OBV34
WR > -80
Entry 1.4
Stop 1
Target 3.7
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Greetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox).
Pra Trading :
- Please care for Money Management
- Have a good psychology
- Do not be hurry to open position and do not do...
EVOK has an analyst sell target at $10. I believe that with a float of 24M, this stock has the stock characteristics to hit $10 and maybe even further. And why is it positive when everything else is down???
WOW, looks pretty cool. Do I want it though, not right now, no...
Its starting to build up is how I look at it. From 3.75 to 4.15 is amazing buying power for you to actually make some AMAZING gains....
Invest Smart
Can't predict the future but it looks promising...
We are extremely pleased to have received FDA approval to commercially market GIMOTI in the United States. This approval represents the first novel pharmaceutical treatment for gastroparesis in several decades. We are excited to be able to offer health care providers and their patients a unique non-oral treatment option to relieve symptoms and help improve their...
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by...
Keep on your watchlist for continuation in price action and buy side volume, looks like accumulation is underway and the fact it is a Pharmaceutical stock, Trial data or FDA releases could be the stimulus.
Very speculative, but very rewarding trade setup on the chart.
COMPANY PROFILE
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the...
